This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castanheira, M.
Right arrow Articles by Gales, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castanheira, M.
Right arrow Articles by Gales, A. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2007, p. 1527-1529, Vol. 51, No. 4
0066-4804/07/$08.00+0     doi:10.1128/AAC.00780-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

First Report of Plasmid-Mediated qnrA1 in a Ciprofloxacin-Resistant Escherichia coli Strain in Latin America{triangledown}

Mariana Castanheira,1* Andrea S. Pereira,1 Adriana G. Nicoletti,1 Antônio C. C. Pignatari,1 Afonso L. Barth,2 and Ana C. Gales1

Laboratório ALERTA, Infectious Diseases Division, Universidade Federal de São Paulo, Sao Paolo, Brazil,1 Unidade de Microbiologia, Serviço de Patologia Clínica, Hospital de Clínicas, Porto Alegre, RS, Brazil2

Received 29 June 2006/ Returned for modification 30 July 2006/ Accepted 27 December 2006


arrow
ABSTRACT
 
Among 144 ciprofloxacin-resistant Escherichia coli isolated in Brazil, one (0.69%) QnrA1-producing isolate was detected. The qnrA1 gene was associated with ISCR1. The QnrA1 determinant was carried on a 41-kb conjugative plasmid, which also carried a FOX-type cephalosporinase encoding gene and a class 1 integron with the aadB and catB3 cassettes. This is the first report of a qnrA-carrying isolate in a Latin American country.


arrow
TEXT
 
The quinolone resistance gene (qnr) was first isolated from an extended-spectrum ß-lactamase-producing Klebsiella pneumoniae strain in Birmingham, AL, in 1998 (4). Since qnrA was characterized, these genes have been reported in E. coli and K. pneumoniae from different regions (5, 8). Recently, a new qnr-type, qnrB, was described in a K. pneumoniae strain and in other members of the Enterobacteriaceae (10). QnrB showed less than 40% amino acid identity with QnrA. Environmental species have been speculated as the likely source of qnr-type determinants (8). The qnr gene has been mostly carried by conjugative plasmids that carry other resistance genes as well (8, 10). Thus, the spread of qnrA is worrisome because it could jeopardize not only the future clinical use of fluoroquinolones but also the use of other unrelated antimicrobial compounds.

From January 2002 to June 2003, a total of 144 ciprofloxacin-resistant Escherichia coli (MIC, ≥4 µg/ml) were isolated from 17 hospital-based laboratories throughout Brazil. Only one isolate per patient was included in the study. A summary description of the demographic data, such as the patient's initials, age, gender, hospitalization ward, and underlying conditions, was obtained. The molecular characterization of these isolates by pulsed-field gel electrophoresis showed a great genomic diversity (data not shown).

All isolates were screened for qnrA by colony blotting and hybridization methods as previously described (13). The qnrA probe was synthesized from a K. pneumoniae strain harboring plasmid pMG252 (4) by PCR with the primers QNRF and QNRR (Table 1). Of the 144 strains, only one qnrA-carrying isolate (strain 13.52) was detected (0.69%). Strain 13.52 was isolated from a urinary specimen of an 80-year-old female who was hospitalized in Porto Alegre, Brazil. This isolate showed resistance to most ß-lactams (except cefepime and carbapenems), all quinolones tested, streptomycin, and chloramphenicol (Table 2) (1). In contrast, this strain was susceptible to gentamicin (MIC, 2 µg/ml), and amikacin (MIC, 4 µg/ml).


View this table:
[in this window]
[in a new window]

  		TABLE 1. Primers used for PCR and sequencing experiments in this study


View this table:
[in this window]
[in a new window]

  		TABLE 2. Susceptibility to selected antimicrobial agents of the qnrA donor (13.52), transconjugant (J53-13.52), and recipient (E. coli J53) strains

PCR amplification and DNA sequencing were performed with the primers listed in Table 1. The amplicons obtained with PCRs were sequenced on both strands using the ABI Prism 377 system (Applied Biosystems, Foster City, CA). The nucleotide sequences were analyzed by using the Lasergene software package (DNASTAR, Madison, WI), and the sequences obtained were compared to sequences available over the internet (http://www.ncbi.nlm.nih.gov/BLAST/).

Investigation of amplicons obtained with primers for qnr and adjacent structures demonstrated that strain 13.52 harbored the same qnrA1 that was originally identified in the plasmid pMG252 carried by a K. pneumoniae strain from Birmingham, AL (GenBank accession number AY070235) (4). DNA sequences produced by further PCR and sequencing experiments assembled a 3,942-bp contiguous sequence (GenBank accession number AM295981). Analysis of this sequence revealed that qnrA was located in a sul1-type integron structure and was embedded downstream of a putative recombinase sequence, orf513, known as common region 1 (ISCR1) (11). The quinolone resistance gene was located immediately upstream of a truncated version of qacE{Delta}1/sul1. This element showed 100% homology to the sul1-type integron structure identified in pMG252 (GenBank accession number DQ831140) (7).

Amplification experiments using primers targeting the conserved regions of class 1 integrons (integrase encoding gene and qacE{Delta}1/sul1) detected a 2.0-kb integron (GenBank accession number AM295980) in the strain 13.52. A walking sequencing strategy revealed two gene cassettes in the variable region of this integron, aadB and catB3, encoding resistance to aminoglycosides and chloramphenicol, respectively. This integron was identical to In-t1 carried by a Salmonella enterica serotype Typhimurium strain isolated from the stool of an infant hospitalized due to acute gastroenteritis at a university hospital in Tirana, Albania (12). Attempts to link the qnrA structure to the integron described above using long-extension PCRs with primers annealing in different positions of the variable region of the class 1 integron and qnrA1 failed, suggesting that these two structures were separate.

Mating experiments were carried out in liquid medium using a streptomycin-resistant E. coli J53 derivative strain. Transconjugants were selected on agar plates containing 10 µg of chloramphenicol/ml and 1,000 µg of streptomycin/ml. The presence of the qnrA and catB3 genes in the selected transconjugants was confirmed by PCR and sequencing with specific primers, showing that both genes were present in the colonies obtained by conjugation. The J53-13.52 strain showed higher fluoroquinolone MICs (Table 2) than previously reported for qnrA transconjugants (fluoroquinolone MICs ranging from 0.25 to 1 µg/ml) (9). Due to this fact, ciprofloxacin, gatifloxacin, and levofloxacin MICs were confirmed by agar dilution according to the method of the Clinical and Laboratory Standards Institute (1). Sequencing of the gyrA and parC quinolone resistance determining regions, performed as previously described (3), revealed that these regions were identical in the donor, recipient, and transconjugant strains and did not contain mutations associated with quinolone resistance.

Mechanisms such as overexpression of the Acr efflux system and alteration in the outer membrane permeability were unlikely to contribute to the high fluoroquinolone resistance levels exhibited by the strain 13.52 and its transconjugant (4) since these mechanisms are chromosomally mediated and could not be transferred. In addition, the MICs for ciprofloxacin and nalidixic acid were not affected in the presence of the pump inhibitors, phenyl-arginine-ß-naphthylamide, and reserpine (6; data not shown). Moreover, the outer membrane protein profile (2) was determined for the clinical (13.52), recipient (E. coli J53), and transconjugant strains. The profiles of the recipient and transconjugant J53-13.52 strains were identical (data not shown).

The high fluoroquinolone resistance level observed in the strain 13.52 and its transconjugant J53-13.52 could possibly be attributed to the association of qnrA1 and a gene encoding the quinolone- and aminoglycoside-modifying enzyme AAC(6')-Ib-cr, as recently described (9). However, PCR with primers targeting this resistance determinant failed to yield positive results with both strain 13.52 and its transconjugant J53-13.52. These results are in accordance with the amikacin susceptibility profile of the strain 13.52 and its transconjugant. Usually, AAC(6')-Ib-cr-producing isolates are resistant to this compound as well as to kanamycin and tobramycin (9).

The mechanism of higher fluoroquinolone resistance conferred by the plasmid carried by strain 13.52, compared to that conferred by other Qnr-encoding plasmids (8. 10), could be attributed to a higher expression of qnrA1 due to a higher plasmid copy number and/or to another yet-unknown plasmid-mediated resistant determinant. Further studies are under way to clarify this issue.

Since several ß-lactamase genes have been found on qnrA-carrying plasmids (8, 10) and ß-lactam resistance was transferred along with quinolone resistance to the transconjugant strain, the presence of ß-lactamases was investigated in strain 13.52 and its transconjugant. The phenotypic detection of extended-spectrum ß-lactamase using clavulanic acid was performed (1). No reduction in the ceftazidime MIC was observed in the presence of clavulanic acid. Primers for the genes encoding some plasmid-encoded class C ß-lactamases, namely, the CMY, DHA, and FOX types, were used to screen for the presence of these genes by PCR (Table 1). PCR results and partial sequencing showed that the strain 13.52 and its transconjugant carried a blaFOX-5-like ß-lactamase gene. Notably, blaFOX-5 was also detected in plasmid pMG252 (10).

Analysis of the plasmid content of the strain 13.52 and the transconjugant J53-13.52 was evaluated by electrophoresis on 0.8% agarose gel of the cleaved and intact plasmid preparation performed with a QIAGEN MIDI kit (QIAGEN, Hilden, Germany). According to the HindIII restriction profile, this strain carried a single plasmid of approximately 41 kb (data not shown).

This is the first report of QnrA-producing E. coli strain in Brazil and Latin America and highlights the potential of plasmid-mediated fluoroquinolone resistance genes such as qnrA1.

The sequences determined in the present study are listed under GenBank accession numbers AM295981 for the qnrA-carrying sul1-type element and AM295980 for the copy of In-t1.


arrow
ACKNOWLEDGMENTS
 
We thank Rosa M. Silva for performing the hybridization experiments.

M.C. and A.S.P. were supported by research grants from the Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP (04/12868-6 and 04/14434-3, respectively).


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Laboratório ALERTA, Universidade Federal de São Paulo, Rua Pedro de Toledo, 781 6o Andar, São Paulo, SP Brazil 04039-032. Phone: 55 11 5084-6538. Fax: 55 11 5571-5180. E-mail: maricastanh{at}yahoo.com Back

{triangledown} Published ahead of print on 12 January 2007. Back


arrow
REFERENCES
 
    1
  1. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement M100-S16. CLSI, Wayne, PA.
    2. 2
  2. Filip, C., G. Fletcher, J. L. Wulff, and C. F. Earhart. 1973. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J. Bacteriol. 115:717-722.[Abstract/Free Full Text]
    3. 3
  3. Gales, A. C., K. A. Gordon, W. W. Wilke, M. A. Pfaller, and R. N. Jones. 2000. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America. Diagn. Microbiol. Infect. Dis. 36:61-64.[CrossRef][Medline]
    4. 4
  4. Jacoby, G. A. 2005. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 41(Suppl. 2):S120-S126.
    5. 5
  5. Jacoby, G. A., N. Chow, and K. B. Waites. 2003. Prevalence of plasmid-mediated quinolone resistance. Antimicrob. Agents Chemother. 47:559-562.[Abstract/Free Full Text]
    6. 6
  6. Kern, W. V., P. Steinke, A. Schumacher, S. Schuster, H. von Baum, and J. A. Bohnert. 2006. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 57:339-343.[Abstract/Free Full Text]
    7. 7
  7. Mammeri, H., L. M. Van De, L. Poirel, L. Martinez-Martinez, and P. Nordmann. 2005. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 49:71-76.[Abstract/Free Full Text]
    8. 8
  8. Nordmann, P., and L. Poirel. 2005. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J. Antimicrob. Chemother. 56:463-469.[Abstract/Free Full Text]
    9. 9
  9. Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, C. H. Park, K. Bush, and D. C. Hooper. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.[CrossRef][Medline]
    10. 10
  10. Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.[CrossRef][Medline]
    11. 11
  11. Toleman, M. A., P. M. Bennett, and T. R. Walsh. 2006. ISCR elements: novel gene-capturing systems of the 21st century? Microbiol. Mol. Biol. Rev. 70:296-316.[Abstract/Free Full Text]
    12. 12
  12. Tosini, F., P. Visca, I. Luzzi, A. M. Dionisi, C. Pezzella, A. Petrucca, and A. Carattoli. 1998. Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype Typhimurium. Antimicrob. Agents Chemother. 42:3053-3058.[Abstract/Free Full Text]
    13. 13
  13. Wang, M., J. H. Tran, G. A. Jacoby, Y. Zhang, F. Wang, and D. C. Hooper. 2003. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47:2242-2248.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, April 2007, p. 1527-1529, Vol. 51, No. 4
0066-4804/07/$08.00+0     doi:10.1128/AAC.00780-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Strahilevitz, J., Jacoby, G. A., Hooper, D. C., Robicsek, A. (2009). Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin. Microbiol. Rev. 22: 664-689 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castanheira, M.
Right arrow Articles by Gales, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castanheira, M.
Right arrow Articles by Gales, A. C.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»